In individuals with schizophrenia, high-dose antipsychotic medication can induce an upregulation of the brain's dopamine D2 receptors (D2Rs), leading to dopamine supersensitivity (DS) or dopamine supersensitivity psychosis (DSP). This evidence concerns the gene DRD2 and psychotic disorder.